Paroxetine Tablet, Film Coated
Product Images NDC 55289-037

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 55289-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (55289037)

Paroxetine 10 mg film-coated tablets prescription label from PD-Rx Pharmaceuticals, Inc. The label shows the product name, strength, dosage form, quantity of 90 tablets, NDC 55289-037-90, and manufacturer information. It includes warnings and directions for use.*

FDA Label Image

Image 01

Chemical structure of paroxetine hydrochloride hemihydrate, showing the molecular arrangement including a fluorophenyl group, a piperidine ring, and a dioxolane fused benzene ring, with HCl and half a water molecule as indicated.*

FDA Label Image

Image 06

A scatter plot chart showing the pharmacokinetic (PK) fold changes with 90% confidence intervals for Cmax and AUC parameters of different interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg) relative to a reference. The x-axis represents the fold change ranging from 0.1 to 10 on a logarithmic scale.*

FDA Label Image

Image 07

A chart showing the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of paroxetine when co-administered with various interacting drugs, including cimetidine 300 mg three times daily, phenobarbital 100 mg once daily, phenytoin 300 mg once daily, digoxin 0.25 mg once daily, and diazepam 5 mg three times daily. The horizontal axis represents change relative to reference (0 to 2).*

FDA Label Image

Image 08

A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) of paroxetine under various conditions including renal impairment (mild, moderate, severe), hepatic impairment, age groups (>65 years) at different doses, and gender (males). The x-axis represents change relative to reference on a logarithmic scale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.